Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Migraine is associated with high brain 5-HT levels as indexed by 5-HT4 receptor binding

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Sleep in cluster headache revisited: Results from a controlled actigraphic study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. CGRP receptor antagonist MK-8825 attenuates cortical spreading depression induced pain behavior

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Sildenafil and calcitonin gene-related peptide dilate intradural arteries: A 3T MR angiography study in healthy volunteers

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Board Walk - July 2019

    Publikation: Bidrag til tidsskriftLederForskningpeer review

  1. Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Association Between Sumatriptan Treatment During a Migraine Attack and Central 5-HT1B Receptor Binding

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Three weeks of SSRI administration enhances the visual perceptual threshold - a randomized placebo-controlled study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Correction: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Introduction: Serotonin (5-HT) plays a role in migraine pathophysiology, but whether brain 5-HT is involved in the conversion from episodic to chronic migraine is unknown. Here, we investigated brain 5-HT levels, as indexed by 5-HT4 receptor binding, in chronic migraine patients and evaluated whether these were associated with migraine frequency. Methods: Sixteen chronic migraine patients underwent a dynamic PET scan after injection of [11C]SB207145, a specific 5-HT4 receptor radioligand. Data from 15 episodic migraine patients and 16 controls were included for comparison. Quantification of 5-HT4 receptor binding was used as a proxy for brain 5-HT levels, since 5-HT4 receptor binding is inversely related to brain 5-HT levels. Results: Chronic migraine patients had 9.1% (95% CI: [−17%; −1.0%]) lower 5-HT4 receptor binding compared to controls (p = 0.039). There was no difference in 5-HT4 receptor binding between chronic and episodic migraine patients (p = 0.48) and no association between number of monthly migraine days and 5-HT4 receptor binding (slope estimate 0.003, 95% CI: [−0.004; 0.715], p = 0.39). Conclusion: The finding of low 5-HT4 receptor binding suggests that cerebral levels of 5-HT are elevated in chronic migraine patients. This is in line with observations made in patients with episodic migraine. Elevated brain 5-HT levels may thus be an inherent trait of the migraine brain rather than a risk factor for conversion from episodic to chronic migraine.

OriginalsprogEngelsk
TidsskriftCephalalgia
Vol/bind39
Udgave nummer4
Sider (fra-til)526-532
Antal sider7
ISSN0333-1024
DOI
StatusUdgivet - apr. 2019

ID: 55587424